It was happening again.
The Professor’s voice had an intensity—and fear—that was impossible to ignore.
He was on the verge of a discovery that could redefine medicine, like a ChatGPT for biology: an AI that could design new medicines to fight cancer, Alzheimer’s, maybe even the next pandemic. The promise was staggering. So was the nightmare. In the wrong hands, the same technology could design a perfect poison, a targeted bioweapon, or a plague we have no defense against.
This wasn’t science fiction. His lab had already created the breakthrough that could turn these possibilities into reality.
As he kept going, I pulled over and parked outside the gathering I was supposed to be attending. The music from the venue rattled my windshield, and I could see throngs of people arriving: employees, ex-employees, colleagues old and new. The board of directors, notably, had not been invited.
